Idiopathic pulmonary arterial hypertension: Current state of play and new treatment modalities

J. Simon R. Gibbs, Craig S. Broberg, Michael A. Gatzoulis

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Research in pulmonary hypertension has led to exciting advances over the last decade, both in terms of understanding aetiology and expanding treatment options. This review highlights the current approach to classification and disease management. In particular, we review the significant data and recommendations on the use of prostacyclin analogues, endothelin receptor antagonists, phosphodiesterase inhibitors and drug combinations.

Original languageEnglish (US)
Pages (from-to)7-10
Number of pages4
JournalInternational Journal of Cardiology
Volume97
Issue numberSUPPL. 1
DOIs
StatePublished - Dec 2004
Externally publishedYes

Keywords

  • Phosphodiesterase
  • Prostacyclin
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Idiopathic pulmonary arterial hypertension: Current state of play and new treatment modalities'. Together they form a unique fingerprint.

Cite this